Psoriasis researchers identify molecular changes responsible for skin discoloration

February 7, 2014 by Leslie Church, Rockefeller University
Leaving a mark. Melanocytes, which give skin its color, are present in healthy skin (top), but increase during a psoriasis flare-up (middle). When the flare-up subsides, the cells are pushed toward the surface, causing dark marks to appear (bottom). Researchers have discovered that two immune system molecules play a role in these pigmentation changes.

(Medical Xpress)—Itchy, painful rashes—such as those that occur with psoriasis—are uncomfortable, but at least they fade when the flare-up subsides. Mostly. Evidence often remains in the form of dark, discolored areas of skin, serving as a reminder of the disease. A new study supported by the Milstein Medical Research Program at The Rockefeller University, however, has uncovered the molecular roots of skin discoloration that is often associated with psoriasis, suggesting the possibility of new treatments for pigmentation changes seen not only in psoriasis, but also in other conditions such as eczema and acne.

In psoriasis, the culprit is a class of immune system molecules known as cytokines. Cytokines play a key role in a signaling process that brings immune cells out to fight off an infection. But two cytokines—interleukin-17 (IL-17) and tumor necrosis factor (TNF)—are overexpressed in psoriasis, leading the immune system to attack a person's own skin cells. It's well-known that these two molecules play an important role in causing the painful rashes that are characteristic of the disease, but Claire Q. Wang, a research associate in James Krueger's Laboratory of Investigative Dermatology, wanted to see if IL-17 and TNF might also have something to do with the dark spots that psoriasis leaves behind.

"One of the treatments for psoriasis is light therapy," says Wang. "Patients will receive artificial UVA and UVB light as a way to reduce inflammation, and although the light doesn't cause sunburn, it was still commonly assumed that this was causing the pigmentation changes. Our research showed that this was not the case."

The scientists found that the IL-17 and TNF cytokines were disrupting the pigment production of patients' melanocytes—the cells that produce melanin, the pigment that gives skin its color. The researchers treated normal human melanocytes with IL-17 and TNF, and found that the two cytokines worked together to suppress . The researchers also looked at the gene expression of from people with psoriasis and found decreased expression of the genes involved in pigmentation signaling, correlated with increased amounts of IL-17 and TNF.

The two cytokines were also found to promote the formation of melanocyte clusters and stimulate the production of growth-promoting cytokines. Psoriasis lesions that contained high levels of IL-17 and TNF also had more melanocytes than healthy skin.

"This was very surprising," says Wang. "Melanocytes are believed to only replicate in the initial growth stage of melanocyte tumors, including melanomas. Here, in psoriasis, their numbers were doubled, sometimes tripled, but this was noncancerous skin. This shows us that these cells are not as dormant in healthy individuals as scientists believe."

This finding, together with the inhibition of pigment function in melanocytes, paints a picture of what's happening in the skin when a flare-up fades.

"During a flare-up, there can be parts of skin with hypopigmentation—white spots," says Wang. "Then after it subsides, the spots turn dark. We think the increase in IL-17 and TNF induces this build-up of melanocytes, but prevents them from expressing the melanin until the inflammation settles down. Then the build-up is released, and the skin shows hyperpigmentation—dark spots."

"Knowing that immune cytokines can change pigment production in melanocytes, while also knowing that chronic inflammation has the potential to increase the number of melanocytes, has clear implications for the design of future therapies to address a set of common skin disorders," says Dr. Krueger, director of Milstein Research Program and D. Martin Carter Professor in Clinical Investigation. "In addition, the results of this study provide new mechanisms for how abnormal pigmentation associated with some melanocytic nevi and melanomas might arise as a result of immune responses to the growths."

Dr. Wang plans to continue studying the effects of TNF and IL-17 on melanocytes, and would like to expand the research to 3D skin models—fabricated samples of tissue in vitro that behave like human skin—that would give a better visual of how the melanin production process is being disrupted by these two cytokines during inflammation or wound healing.

Explore further: Researchers identify new target to treat psoriasis

More information: "IL-17 and TNF Synergistically Modulate Cytokine Expression while Suppressing Melanogenesis: Potential Relevance to Psoriasis." Claire Q F Wang, Yemsratch T Akalu, Mayte Suarez-Farinas, Juana Gonzalez, Hiroshi Mitsui, Michelle A Lowes, Seth J Orlow, Prashiela Manga and James G Krueger. Journal of Investigative Dermatology (2013) 133, 2741–2752; DOI: 10.1038/jid.2013.237; published online 27 June 2013

Related Stories

Researchers identify new target to treat psoriasis

December 5, 2013
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, ...

Protein may be key to psoriasis and wound care

June 21, 2012
Psoriasis is an autoimmune disorder in which skin cells proliferate out of control. For some hard-to-heal wounds, the problem is just the opposite: Restorative skin cells don't grow well or fast enough. In a paper published ...

Skin care tips for psoriasis patients

August 25, 2013
(HealthDay)—Sun protection is among the skin care habits that can help people with the chronic skin condition psoriasis reduce some of the discomfort they may experience, such as skin itching, cracking and bleeding, an ...

Topical treatment for psoriasis targets deeper layers of the skin, improves healing

November 14, 2013
A novel combination anti-psoriasis therapy has potential for superior and longer-lasting therapeutic effects than current topical treatments by targeting genetic abnormalities in deeper layers of the skin. This research is ...

Weight loss might ease psoriasis, study hints

May 29, 2013
(HealthDay)—People with psoriasis who lose weight could experience some relief from the symptoms of their chronic skin disease, according to a small new study.

Vitamin D analogs modulate immunity in psoriasis

March 9, 2012
(HealthDay) -- Vitamin D3 analogs modulate immunity in human psoriasis, inducing thymic stromal lymphopoietin (TSLP) and cathelicidin, according to a study published online March 2 in the British Journal of Dermatology.

Recommended for you

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.